What_WP kind_NN of_IN evidence_NN is_VBZ it_PP that_IN Evidence-Based_JJ Medicine_NP advocates_NNS want_VBP health_NN care_NN providers_NNS and_CC consumers_NNS to_TO pay_VB attention_NN to_TO ?_SENT Abstract_NN |_SYM Background_NN |_SYM In_IN 1992_CD ,_, Evidence-Based_JJ Medicine_NP advocates_NNS proclaimed_VBD a_DT "_`` new_JJ paradigm_NN "_'' ,_, in_IN which_WDT evidence_NN from_IN health_NN care_NN research_NN is_VBZ the_DT best_JJS basis_NN for_IN decisions_NNS for_IN individual_JJ patients_NNS and_CC health_NN systems_NNS ._SENT Hailed_VBN in_IN New_NP York_NP Times_NP Magazine_NP in_IN 2001_CD as_IN one_CD of_IN the_DT most_RBS influential_JJ ideas_NNS of_IN the_DT year_NN ,_, this_DT approach_NN was_VBD initially_RB and_CC provocatively_RB pitted_VBN against_IN the_DT traditional_JJ teaching_NN of_IN medicine_NN ,_, in_IN which_WDT the_DT key_JJ elements_NNS of_IN knowing_VBG for_IN clinical_JJ purposes_NNS are_VBP understanding_VBG of_IN basic_JJ pathophysiologic_JJ mechanisms_NNS of_IN disease_NN coupled_VBN with_IN clinical_JJ experience_NN ._SENT This_DT paper_NN reviews_VBZ the_DT origins_NNS ,_, aspirations_NNS ,_, philosophical_JJ limitations_NNS ,_, and_CC practical_JJ challenges_NNS of_IN evidence-based_JJ medicine_NN ._SENT Discussion_NN |_SYM EBM_NP has_VBZ long_RB since_RB evolved_VBN beyond_IN its_PP$ initial_JJ (mis)conception_NN ,_, that_WDT EBM_NP might_MD replace_VB traditional_JJ medicine_NN ._SENT EBM_NP is_VBZ now_RB attempting_VBG to_TO augment_VB rather_RB than_IN replace_VB individual_JJ clinical_JJ experience_NN and_CC understanding_NN of_IN basic_JJ disease_NN mechanisms_NNS ._SENT EBM_NP must_MD continue_VB to_TO evolve_VB ,_, however_RB ,_, to_TO address_VB a_DT number_NN of_IN issues_NNS including_VBG scientific_JJ underpinnings_NNS ,_, moral_JJ stance_NN and_CC consequences_NNS ,_, and_CC practical_JJ matters_NNS of_IN dissemination_NN and_CC application_NN ._SENT For_IN example_NN ,_, accelerating_VBG the_DT transfer_NN of_IN research_NN findings_NNS into_IN clinical_JJ practice_NN is_VBZ often_RB based_VBN on_IN incomplete_JJ evidence_NN from_IN selected_JJ groups_NNS of_IN people_NNS ,_, who_WP experience_VBP a_DT marginal_JJ benefit_NN from_IN an_DT expensive_JJ technology_NN ,_, raising_VBG issues_NNS of_IN the_DT generalizability_NN of_IN the_DT findings_NNS ,_, and_CC increasing_VBG problems_NNS with_IN how_WRB many_JJ and_CC who_WP can_MD afford_VB the_DT new_JJ innovations_NNS in_IN care_NN ._SENT Summary_NN |_SYM Advocates_NNS of_IN evidence-based_JJ medicine_NN want_VBP clinicians_NNS and_CC consumers_NNS to_TO pay_VB attention_NN to_TO the_DT best_JJS findings_NNS from_IN health_NN care_NN research_NN that_WDT are_VBP both_CC valid_JJ and_CC ready_JJ for_IN clinical_JJ application_NN ._SENT Much_RB remains_VBZ to_TO be_VB done_VBN to_TO reach_VB this_DT goal_NN ._SENT Evidence-Based_NP Medicine_NP (_( EBM_NP )_) is_VBZ based_VBN on_IN the_DT notion_NN that_IN clinicians_NNS ,_, if_IN they_PP are_VBP to_TO provide_VB ,_, and_CC continue_VBP to_TO provide_VB ,_, optimal_JJ care_NN for_IN their_PP$ patients_NNS ,_, need_VBP to_TO know_VB enough_RB about_RB applied_VBN research_NN principles_NNS to_TO detect_VB studies_NNS published_VBN in_IN the_DT medical_JJ literature_NN that_WDT are_VBP both_CC scientifically_RB strong_JJ and_CC ready_JJ for_IN clinical_JJ application_NN ._SENT This_DT opportunity_NN for_IN continuing_VBG to_TO improve_VB the_DT quality_NN of_IN medical_JJ care_NN stems_VBZ from_IN the_DT huge_JJ ongoing_JJ public_NN and_CC private_JJ investment_NN in_IN biomedical_JJ and_CC health_NN research_NN ._SENT The_DT challenges_NNS in_IN applying_VBG new_JJ knowledge_NN ,_, however_RB ,_, are_VBP considerable_JJ ,_, and_CC EBM_NP does_VBZ not_RB address_VB them_PP all_DT ._SENT Two_CD that_IN EBM_NP tries_VBZ to_TO address_VB are_VBP as_RB follows_VBZ ._SENT First_RB ,_, the_DT advance_NN of_IN knowledge_NN is_VBZ incremental_JJ ,_, with_IN many_JJ false_JJ steps_NNS ,_, and_CC with_IN breakthroughs_NNS few_JJ and_CC far_RB between_IN ,_, so_RB that_IN only_RB a_DT very_RB tiny_JJ fraction_NN of_IN the_DT reports_NNS in_IN the_DT medical_JJ literature_NN signal_NN new_JJ knowledge_NN that_WDT is_VBZ both_DT adequately_RB tested_VBN and_CC important_JJ enough_NN for_IN practitioners_NNS to_TO depend_VB upon_RP and_CC apply_VB ._SENT Second_RB ,_, practitioners_NNS have_VBP limited_VBN time_NN and_CC little_JJ understanding_NN of_IN research_NN methods_NNS ._SENT To_TO help_VB practitioners_NNS meet_VB these_DT challenges_NNS ,_, EBM_NP advocates_NNS have_VBP created_VBN procedures_NNS to_TO objectively_RB identify_VB and_CC summarize_VB evidence_NN as_IN it_PP accumulates_VBZ on_IN clinical_JJ topics_NNS ,_, and_CC resources_NNS that_WDT allow_VBP users_NNS to_TO find_VB the_DT current_JJ best_JJS evidence_NN when_WRB and_CC where_WRB it_PP is_VBZ needed_VBN for_IN decisions_NNS concerning_VBG health_NN and_CC health_NN care_NN ._SENT This_DT paper_NN reviews_VBZ the_DT origins_NNS ,_, aspirations_NNS ,_, philosophical_JJ limitations_NNS ,_, and_CC practical_JJ challenges_NNS of_IN evidence-based_JJ medicine_NN ._SENT The_DT history_NN and_CC precepts_NNS of_IN EBM_NP |_SYM Evidence-Based_JJ Medicine_NP (_( EBM_NP )_) ,_, the_DT term_NN and_CC current_JJ concepts_NNS ,_, originated_VBN from_IN clinical_JJ epidemiologists_NNS at_IN McMaster_NP University_NP ._SENT Although_IN the_DT term_NN has_VBZ been_VBN adopted_VBN by_IN many_JJ disciplines_NNS and_CC adapted_VBN to_TO their_PP$ use_NN (_( eg_NN ,_, as_IN Evidence-Based_JJ Nursing_NP ,_, Evidence-Based_JJ Clinical_NP Practice_NP ,_, Evidence-Based_NP Pharmacy_NP ,_, and_CC so_RB on_RB )_) ,_, the_DT objectives_NNS of_IN these_DT congeners_NNS are_VBP the_DT same_JJ and_CC I_PP will_MD use_VB the_DT generic_JJ term_NN in_IN this_DT essay_NN ._SENT EBM_NN advocates_NNS want_VBP patients_NNS ,_, practitioners_NNS ,_, health_NN care_NN managers_NNS and_CC policy_NN makers_NNS to_TO pay_VB attention_NN to_TO the_DT best_JJS findings_NNS from_IN health_NN care_NN research_NN that_WDT meet_VBP the_DT dual_JJ requirements_NNS of_IN being_VBG both_DT scientifically_RB valid_JJ and_CC ready_JJ for_IN clinical_JJ application_NN ._SENT In_IN doing_VBG so_RB ,_, EBM_NP advocates_NNS proclaimed_VBD a_DT new_JJ paradigm_NN and_CC seemingly_RB pitted_VBN EBM_NP against_IN the_DT traditional_JJ knowledge_NN foundation_NN of_IN medicine_NN ,_, in_IN which_WDT the_DT key_JJ elements_NNS are_VBP understanding_VBG of_IN basic_JJ mechanisms_NNS of_IN disease_NN coupled_VBN with_IN clinical_JJ experience_NN ._SENT The_DT latter_NN is_VBZ epitomized_VBN by_IN the_DT individual_JJ authority_NN (_( "_`` expert_NN "_'' )_) ,_, or_CC ,_, better_RBR still_RB ,_, collective_JJ medical_JJ authority_NN ,_, such_JJ as_IN a_DT panel_NN of_IN experts_NNS convened_VBN by_IN a_DT professional_JJ society_NN to_TO provide_VB practice_NN guidelines_NNS based_VBN on_IN collective_JJ expert_NN opinion_NN ._SENT EBM_NP claims_VBZ that_IN experts_NNS are_VBP more_RBR fallible_JJ in_IN their_PP$ recommendations_NNS (_( of_IN what_WP works_VBZ and_CC what_WP does_VBZ n't_RB work_VB in_IN caring_VBG for_IN patients_NNS )_) than_IN evidence_NN derived_VBN from_IN sound_JJ systematic_JJ observation_NN (_( that_WDT is_VBZ ,_, health_NN care_NN research_NN )_) ._SENT This_DT is_VBZ especially_RB so_RB during_IN recent_JJ decades_NNS when_WRB applied_VBN research_NN methods_NNS have_VBP been_VBN developed_VBN for_IN observation_NN and_CC experimentation_NN in_IN increasingly_RB naturalistic_JJ and_CC complex_JJ clinical_JJ settings_NNS ._SENT Furthermore_RB ,_, because_IN applied_VBN research_NN methods_NNS are_VBP based_VBN on_IN assessing_VBG probabilities_NNS for_IN relationships_NNS and_CC the_DT effects_NNS of_IN interventions_NNS ,_, rather_RB than_IN underlying_VBG mechanistic_JJ explanations_NNS ,_, EBM_NP posits_VBZ that_IN practitioners_NNS must_MD be_VB ready_JJ to_TO accept_VB and_CC deal_VB with_IN uncertainty_NN (_( rather_RB than_IN seeking_VBG the_DT reductionist_NN allure_NN of_IN basic_JJ science_NN )_) ,_, and_CC to_TO acknowledge_VB that_IN management_NN decisions_NNS are_VBP often_RB made_VBN in_IN the_DT face_NN of_IN relative_JJ ignorance_NN of_IN their_PP$ underlying_VBG nature_NN or_CC true_JJ impact_NN for_IN individual_JJ patients_NNS ._SENT A_DT fundamental_JJ assumption_NN of_IN EBM_NP is_VBZ that_DT practitioners_NNS whose_WP$ practice_NN is_VBZ based_VBN on_IN an_DT understanding_NN of_IN evidence_NN from_IN applied_JJ health_NN care_NN research_NN will_MD provide_VB superior_JJ patient_JJ care_NN compared_VBN with_IN practitioners_NNS who_WP rely_VBP on_IN understanding_NN of_IN basic_JJ mechanisms_NNS and_CC their_PP$ own_JJ clinical_JJ experience_NN ._SENT So_RB far_RB ,_, no_DT convincing_JJ direct_JJ evidence_NN exists_VBZ that_IN shows_NNS that_IN this_DT assumption_NN is_VBZ correct_JJ ._SENT Nevertheless_RB ,_, the_DT New_NP York_NP Times_NP Magazine_NP "_'' Year_NN in_IN Review_NP "_'' included_VBD EBM_NP as_IN one_CD of_IN the_DT most_RBS influential_JJ ideas_NNS of_IN 2001_CD ._SENT Basic_JJ versus_CC applied_JJ health_NN research_NN |_SYM Scientific_JJ approaches_NNS to_TO studying_VBG health_NN care_NN problems_NNS developed_VBN at_IN a_DT leisurely_JJ pace_NN until_IN the_DT end_NN of_IN World_NP War_NP II_NP when_WRB some_DT of_IN the_DT public_JJ funding_NN that_WDT had_VBD been_VBN dedicated_VBN to_TO killing_VBG was_VBD reallocated_VBN to_TO saving_VBG lives_NNS through_IN health_NN research_NN ._SENT Initial_JJ investments_NNS were_VBD directed_VBN firstly_RB to_TO basic_JJ research_NN ,_, to_TO better_RBR understand_VB the_DT determinants_NNS and_CC pathophysiology_NN of_IN disease_NN ,_, and_CC medical_JJ schools_NNS reflected_VBD this_DT stage_NN of_IN development_NN in_IN their_PP$ teaching_NN of_IN the_DT basic_JJ sciences_NNS of_IN biology_NN ,_, pathology_NN ,_, physiology_NN and_CC biochemistry_NN ,_, as_IN the_DT foundation_NN of_IN medical_JJ knowledge_NN ._SENT Increasing_VBG shares_NNS of_IN investment_NN were_VBD then_RB allocated_VBN to_TO the_DT development_NN and_CC applied_VBN testing_NN of_IN innovations_NNS in_IN clinical_JJ settings_NNS ._SENT Although_IN these_DT applied_VBN research_NN methods_NNS were_VBD initially_RB rooted_VBN in_IN the_DT observational_JJ techniques_NNS of_IN epidemiology_NN ,_, clinical_JJ epidemiologists_NNS such_JJ as_IN Archie_NP Cochrane_NP in_IN the_DT UK_NP ,_, Alvan_NP Feinstein_NP in_IN the_DT US_NP ,_, and_CC David_NP Sackett_NP in_IN Canada_NP ,_, pioneered_VBD and_CC legitimized_VBD the_DT use_NN of_IN experimentation_NN in_IN clinical_JJ settings_NNS ,_, leading_VBG to_TO the_DT randomized_VBN controlled_JJ trial_NN becoming_VBG the_DT hallmark_NN of_IN testing_NN ._SENT It_PP is_VBZ important_JJ to_TO recognize_VB that_IN experimental_JJ designs_NNS were_VBD added_VBN to_TO observational_JJ designs_NNS ,_, not_RB substituted_VBN for_IN them_PP ._SENT Different_JJ methods_NNS ,_, observational_JJ or_CC experimental_JJ ,_, are_VBP needed_VBN for_IN exploring_VBG different_JJ questions_NNS ._SENT The_DT first_JJ trial_NN in_IN which_WDT randomization_NN was_VBD formally_RB described_VBN and_CC applied_VBN was_VBD published_VBN in_IN the_DT British_NP Medical_NP Journal_NP in_IN 1948_CD and_CC heralded_VBN a_DT new_JJ era_NN of_IN antibiotic_JJ treatment_NN ,_, streptomycin_NN for_IN tuberculosis_NN ._SENT Today_NN ,_, methodologies_NNS from_IN other_JJ scientific_JJ disciplines_NNS have_VBP been_VBN added_VBN ._SENT For_IN example_NN ,_, nonexperimental_JJ and_CC qualitative_JJ research_NN methods_NNS have_VBP been_VBN adopted_VBN from_IN the_DT social_JJ sciences_NNS ._SENT Thus_RB ,_, the_DT research_NN methods_NNS of_IN medical_JJ science_NN are_VBP pluralistic_JJ and_CC expanding_VBG ,_, driven_VBN by_IN attempts_NNS to_TO address_VB a_DT broader_JJR range_NN of_IN questions_NNS ,_, and_CC undoubtedly_RB by_IN the_DT priority_NN that_IN people_NNS place_VBP on_IN personal_JJ health_NN ,_, the_DT obvious_JJ benefits_NNS that_IN biomedical_JJ research_NN has_VBZ already_RB brought_VBN ,_, and_CC the_DT prospect_NN that_IN these_DT benefits_NNS are_VBP just_RB the_DT beginning_NN ._SENT EBM_NP does_VBZ not_RB clearly_RB address_VB the_DT role_NN of_IN basic_JJ science_NN in_IN medical_JJ discovery_NN ,_, except_IN to_TO indicate_VB that_IN ,_, in_IN most_JJS circumstances_NNS of_IN relevance_NN to_TO individual_JJ patient_JJ care_NN ,_, basic_JJ science_NN alone_RB does_VBZ not_RB provide_VB valid_JJ and_CC practical_JJ guidance_NN ._SENT There_EX are_VBP some_DT exceptions_NNS :_: certain_JJ deficiency_NN disorders_NNS ,_, such_JJ as_IN type_NN 1_CD diabetes_NN mellitus_NN ,_, for_IN example_NN ._SENT However_RB ,_, even_RB though_IN basic_JJ science_NN provides_VBZ definitive_JJ evidence_NN that_IN insulin_NN deficiency_NN is_VBZ the_DT underlying_VBG problem_NN in_IN this_DT disorder_NN ,_, determining_VBG which_WDT of_IN many_JJ possible_JJ ways_NNS of_IN delivering_VBG exogenous_JJ insulin_NN therapy_NN results_NNS in_IN the_DT best_JJS care_NN for_IN patients_NNS has_VBZ required_VBN myriads_NNS of_IN applied_VBN research_NN studies_NNS ,_, with_IN clear_JJ evidence_NN concerning_VBG the_DT benefit_NN of_IN multiple_JJ dose_NN insulin_NN regimens_NNS coming_VBG less_JJR than_IN a_DT decade_NN ago_RB ._SENT In_IN many_JJ such_JJ situations_NNS ,_, empirical_JJ solutions_NNS ,_, tested_VBN by_IN applied_VBN research_NN methods_NNS ,_, are_VBP "_`` holding_VBG the_DT fort_NN "_'' until_IN basic_JJ understanding_NN --_: of_IN mechanisms_NNS and_CC interventions_NNS --_: is_VBZ forthcoming_JJ ._SENT This_DT will_MD continue_VB to_TO be_VB the_DT case_NN for_IN the_DT foreseeable_JJ future_NN ,_, the_DT marvelous_JJ advances_NNS in_IN genomics_NNS notwithstanding_RB ._SENT This_DT schism_NN between_IN basic_JJ and_CC applied_JJ research_NN is_VBZ ,_, however_RB ,_, more_JJR rhetoric_NN than_IN reality_NN ._SENT Rather_RB ,_, basic_JJ and_CC applied_JJ research_NN are_VBP different_JJ ends_NNS of_IN a_DT spectrum_NN of_IN health_NN research_NN ,_, progressing_VBG from_IN "_`` bench_NN "_'' to_TO "_`` bedside_NN "_'' ._SENT The_DT best_RBS applied_JJ research_NN studies_NNS are_VBP often_RB founded_VBN on_IN excellent_JJ basic_JJ science_NN findings_NNS ,_, even_RB if_IN basic_JJ research_NN is_VBZ neither_RB necessary_JJ nor_CC sufficient_JJ for_IN the_DT management_NN of_IN most_JJS medical_JJ problems_NNS ._SENT This_DT is_VBZ because_RB applied_VBN research_NN is_VBZ a_DT complementary_JJ way_NN of_IN knowing_VBG ,_, not_RB a_DT participant_NN in_IN a_DT scientific_JJ turf_NN war_NN competing_VBG to_TO be_VB the_DT best_JJS way_NN of_IN knowing_VBG ._SENT Nevertheless_RB ,_, from_IN a_DT pragmatic_JJ ,_, clinical_JJ focus_NN ,_, applied_VBN research_NN provides_VBZ evidence_NN to_TO practitioners_NNS and_CC patients_NNS that_WDT is_VBZ often_RB better_RBR suited_VBN for_IN the_DT specific_JJ problems_NNS they_PP must_MD deal_VB with_IN ._SENT Confusion_NN between_IN the_DT objectives_NNS of_IN science_NN and_CC those_DT of_IN the_DT practice_NN of_IN medicine_NN has_VBZ perhaps_RB led_VBN to_TO much_JJ of_IN the_DT misunderstanding_NN and_CC criticism_NN leveled_VBN at_IN EBM_NP ._SENT An_DT example_NN of_IN the_DT interplay_NN between_IN basic_JJ and_CC applied_JJ clinical_JJ research_NN |_SYM An_DT example_NN illustrates_VBZ the_DT complex_JJ relationship_NN between_IN basic_JJ and_CC applied_JJ research_NN ,_, and_CC in_IN turn_NN ,_, between_IN both_DT of_IN these_DT and_CC clinical_JJ practice_NN ._SENT Narrowing_VBG of_IN the_DT arteries_NNS to_TO the_DT front_JJ part_NN of_IN the_DT brain_NN (_( the_DT internal_JJ carotid_JJ artery_NN and_CC its_PP$ tributaries_NNS ,_, the_DT anterior_JJ and_CC middle_JJ cerebral_JJ arteries_NNS )_) is_VBZ associated_VBN with_IN stroke_NN ,_, in_IN which_WDT a_DT part_NN of_IN the_DT brain_NN dies_VBZ when_WRB it_PP loses_VBZ its_PP$ blood_NN supply_NN ._SENT Narrowings_NNS of_IN the_DT internal_JJ carotid_JJ artery_NN above_IN the_DT level_NN of_IN the_DT neck_NN can_MD be_VB bypassed_VBN through_IN connecting_VBG the_DT superficial_JJ temporal_JJ artery_NN (_( STA_NP )_) ,_, on_IN the_DT outside_NN of_IN the_DT head_NN ,_, with_IN a_DT branch_NN of_IN the_DT middle_JJ cerebral_JJ artery_NN (_( MCA_NP )_) ,_, just_RB inside_IN the_DT skull_NN ._SENT STA-MCA_NP bypass_NN (_( also_RB known_VBN as_IN extracranial-intracranial_JJ (_( EC/IC_JJ )_) bypass_NN )_) is_VBZ an_DT elegant_JJ (_( and_CC expensive_JJ )_) surgical_JJ procedure_NN that_WDT is_VBZ both_DT technically_RB feasible_JJ in_IN a_DT high_JJ proportion_NN of_IN cases_NNS and_CC leads_VBZ to_TO increased_VBN blood_NN supply_NN to_TO the_DT part_NN of_IN the_DT brain_NN beyond_IN the_DT narrowing_NN of_IN the_DT ICA_NN ._SENT This_DT increased_VBN blood_NN supply_NN was_VBD thought_VBN ,_, on_IN physiological_JJ grounds_NNS ,_, to_TO be_VB exactly_RB what_WP the_DT brain_NN needed_VBD to_TO prevent_VB future_JJ strokes_NNS in_IN people_NNS who_WP had_VBD had_VBN minor_JJ strokes_NNS in_IN this_DT vascular_JJ distribution_NN ._SENT About_RB 200_CD reports_NNS of_IN case_NN series_NN of_IN patients_NNS undergoing_VBG STA-MCA_NP bypass_NN were_VBD reported_VBN in_IN the_DT medical_JJ literature_NN up_RB to_TO 1985_CD ,_, almost_RB all_RB of_IN them_PP interpreted_VBD by_IN their_PP$ surgeon_NN authors_NNS as_IN indicating_VBG benefits_NNS for_IN patients_NNS ._SENT In_IN these_DT case_NN series_NN studies_NNS ,_, patients_NNS are_VBP described_VBN before_IN and_CC after_IN undergoing_VBG the_DT procedure_NN ,_, and_CC sometimes_RB compared_VBN with_IN findings_NNS in_IN previous_JJ reports_NNS (_( "_`` historical_JJ controls_NNS "_'' )_) ,_, with_IN and_CC without_IN the_DT procedure_NN ._SENT In_IN 1985_CD ,_, a_DT large_JJ randomized_VBN controlled_JJ trial_NN was_VBD reported_VBN ._SENT This_DT showed_VBD no_DT reduction_NN in_IN the_DT subsequent_JJ rate_NN of_IN stroke_NN with_IN the_DT procedure_NN when_WRB compared_VBN with_IN the_DT rate_NN for_IN patients_NNS who_WP did_VBD not_RB have_VB the_DT procedure_NN ._SENT On_IN further_JJR analysis_NN ,_, it_PP was_VBD found_VBN that_IN patients_NNS with_IN STA-MCA_NP bypass_NN who_WP had_VBD higher_JJR rates_NNS of_IN blood_NN flow_NN were_VBD actually_RB worse_JJR off_RP ,_, and_CC that_DT surgery_NN blunted_VBD the_DT natural_JJ rate_NN of_IN recovery_NN from_IN the_DT initial_JJ stroke_NN that_WDT led_VBD to_TO selection_NN of_IN patients_NNS for_IN surgery_NN ._SENT Dissemination_NN of_IN these_DT findings_NNS was_VBD rapid_JJ and_CC led_VBN to_TO the_DT elimination_NN of_IN this_DT procedure_NN for_IN attempting_VBG to_TO prevent_VB stroke_NN recurrence_NN ._SENT Subsequently_RB ,_, randomized_VBD controlled_JJ trials_NNS were_VBD conducted_VBN for_IN patients_NNS with_IN narrowing_VBG of_IN the_DT internal_JJ carotid_JJ artery_NN in_IN the_DT neck_NN ._SENT Removing_VBG this_DT narrowing_NN surgically_RB ,_, a_DT procedure_NN called_VBD carotid_JJ endarterectomy_NN ,_, had_VBD been_VBN practiced_VBN for_IN longer_JJR than_IN STA-MCA_NP bypass_NN at_IN the_DT time_NN but_CC had_VBD not_RB been_VBN adequately_RB tested_VBN in_IN controlled_JJ trials_NNS ._SENT Its_PP$ use_NN was_VBD brought_VBN into_IN question_NN because_IN of_IN the_DT negative_JJ findings_NNS of_IN the_DT STA-MCA_NP bypass_NN trial_NN ,_, which_WDT appeared_VBD to_TO undermine_VB the_DT physiological_JJ rationale_NN for_IN the_DT procedure_NN ,_, namely_RB ,_, that_IN opening_VBG a_DT partially_RB blocked_VBN internal_JJ carotid_JJ artery_NN would_MD reduce_VB the_DT risk_NN for_IN subsequent_JJ stroke_NN ._SENT As_IN it_PP happens_VBZ ,_, several_JJ randomized_VBD controlled_VBN trials_NNS of_IN carotid_JJ endarterectomy_NN that_WDT ensued_VBD showed_VBD that_IN it_PP has_VBZ substantial_JJ benefit_NN for_IN symptomatic_JJ patients_NNS with_IN severe_JJ narrowing_NN of_IN the_DT carotid_JJ artery_NN ,_, but_CC not_RB for_IN those_DT who_WP had_VBD mild_JJ narrowing_NN or_CC who_WP had_VBD no_DT symptoms_NNS associated_VBN with_IN the_DT narrowing_NN ._SENT These_DT trials_NNS of_IN STA-MCA_NP bypass_NN and_CC carotid_JJ endarterectomy_NN have_VBP led_VBN to_TO better_JJR understanding_NN of_IN the_DT basic_JJ mechanisms_NNS of_IN stroke_NN ,_, elimination_NN of_IN a_DT harmful_JJ surgical_JJ procedure_NN ,_, promotion_NN of_IN another_DT procedure_NN ,_, and_CC provision_NN of_IN evidence_NN for_IN tailoring_VBG the_DT findings_NNS to_TO individual_JJ patients_NNS ._SENT These_DT advances_NNS in_IN knowledge_NN have_VBP benefited_VBN many_JJ patients_NNS ._SENT Unfortunately_RB ,_, surveys_NNS of_IN patient_NN care_VBP also_RB show_VB that_IN some_DT patients_NNS receive_VBP endarterectomy_NN when_WRB they_PP are_VBP unlikely_JJ to_TO benefit_VB from_IN it_PP ,_, while_IN others_NNS who_WP might_MD benefit_VB are_VBP not_RB offered_VBN it_PP ._SENT In_IN fact_NN ,_, there_EX are_VBP numerous_JJ examples_NNS of_IN underapplied_JJ evidence_NN of_IN both_CC the_DT benefits_NNS and_CC harms_NNS of_IN treatments_NNS ._SENT Eliminating_VBG this_DT mismatch_NN between_IN who_WP could_MD benefit_VB and_CC who_WP is_VBZ offered_VBN health_NN care_NN interventions_NNS is_VBZ the_DT prime_JJ objective_NN of_IN EBM_NP ._SENT The_DT nuts_NNS and_CC bolts_NNS of_IN EBM_NP |_SYM A_DT current_JJ definition_NN of_IN EBM_NP is_VBZ "_`` the_DT explicit_JJ ,_, judicious_JJ ,_, and_CC conscientious_JJ use_NN of_IN current_JJ best_JJS evidence_NN from_IN health_NN care_NN research_NN in_IN decisions_NNS about_IN the_DT care_NN of_IN individuals_NNS and_CC populations_NNS "_'' ._SENT A_DT more_RBR pragmatic_JJ definition_NN is_VBZ a_DT set_NN of_IN tools_NNS and_CC resources_NNS for_IN finding_VBG and_CC applying_VBG current_JJ best_JJS evidence_NN from_IN research_NN for_IN the_DT care_NN of_IN individual_JJ patients_NNS ._SENT This_DT practical_JJ definition_NN reflects_VBZ the_DT fact_NN that_IN there_EX are_VBP now_RB many_JJ information_NN resources_NNS in_IN which_WDT evidence_NN from_IN health_NN care_NN research_NN has_VBZ been_VBN pre-graded_VBN for_IN validity_NN by_IN people_NNS with_IN expertise_NN in_IN research_NN methods_NNS ,_, and_CC ,_, better_RBR still_RB ,_, also_RB assessed_VBN by_IN experienced_JJ practitioners_NNS for_IN clinical_JJ relevance_NN ._SENT Thus_RB ,_, the_DT user_NN 's_POS task_NN is_VBZ changing_VBG from_IN the_DT largely_RB hopeless_JJ one_CD of_IN reading_VBG the_DT original_JJ medical_JJ literature_NN to_TO find_VB out_RP about_IN current_JJ best_JJS care_NN ,_, to_TO one_CD of_IN finding_VBG the_DT right_JJ pre-assessed_JJ research_NN evidence_NN ,_, judging_VBG whether_IN it_PP applies_VBZ to_TO the_DT health_NN problem_NN at_IN hand_NN ,_, and_CC then_RB working_VBG the_DT evidence_NN into_IN the_DT decision_NN that_WDT must_MD be_VB made_VBN ._SENT Grades_NNS of_IN the_DT quality_NN of_IN evidence_NN are_VBP derived_VBN from_IN scientific_JJ principles_NNS of_IN epidemiology_NN and_CC its_PP$ offspring_NNS ,_, clinical_JJ epidemiology_NN ._SENT The_DT grades_NNS are_VBP based_VBN on_IN several_JJ notions_NNS ,_, the_DT most_RBS elementary_JJ of_IN which_WDT are_VBP as_RB follows_VBZ ._SENT First_RB ,_, studies_NNS that_WDT take_VBP more_JJR precautions_NNS to_TO minimize_VB the_DT risk_NN of_IN bias_NN (_( for_IN example_NN ,_, through_IN using_VBG reliable_JJ and_CC valid_JJ measures_NNS of_IN health_NN care_NN outcomes_NNS )_) are_VBP more_RBR likely_JJ to_TO reveal_VB useful_JJ truths_NNS than_IN those_DT that_WDT take_VBP fewer_JJR precautions_NNS ._SENT Second_RB ,_, studies_NNS based_VBN in_IN patient_JJ populations_NNS that_IN more_RBR closely_RB resemble_VB those_DT that_WDT exist_VBP in_IN usual_JJ clinical_JJ practice_NN are_VBP more_RBR likely_JJ to_TO provide_VB valid_JJ and_CC useful_JJ information_NN for_IN clinical_JJ practice_NN than_IN studies_NNS based_VBN on_IN organisms_NNS in_IN test_NN tubes_NNS ,_, creatures_NNS in_IN cages_NNS ,_, very_RB select_VB human_JJ populations_NNS ,_, or_CC unachievable_JJ clinical_JJ circumstances_NNS (_( such_JJ as_IN extra_JJ staff_NN to_TO provide_VB intensive_JJ follow_VBP up_RP ,_, far_RB beyond_IN the_DT resources_NNS in_IN usual_JJ clinical_JJ settings_NNS )_) ._SENT Third_JJ ,_, studies_VBZ that_IN measure_NN clinical_JJ outcomes_NNS that_WDT are_VBP more_RBR important_JJ to_TO patients_NNS (_( eg_NP ,_, mortality_NN ,_, morbidity_NN and_CC quality_NN of_IN life_NN ,_, rather_RB than_IN liver_NN enzymes_NNS and_CC serum_NN electrolytes_NNS )_) are_VBP more_RBR likely_JJ to_TO provide_VB evidence_NN that_WDT is_VBZ important_JJ to_TO both_DT practitioners_NNS and_CC patients_NNS ._SENT Simple_JJ guidelines_NNS for_IN critical_JJ appraisal_NN of_IN health_NN care_NN research_NN evidence_NN are_VBP widely_RB available_JJ in_IN print_NN [_SYM for_IN example_NN ,_, ]_SYM and_CC on_IN the_DT internet_NN (_( for_IN example_NN ,_, )_) ._SENT Optimal_JJ study_NN designs_NNS differ_VBP for_IN determining_VBG the_DT cause_NN ,_, course_NN ,_, diagnosis_NN ,_, prognosis_NN ,_, prevention_NN ,_, therapy_NN and_CC rehabilitation_NN of_IN disease_NN ,_, so_RB the_DT rules_NNS for_IN assessing_VBG validity_NN differ_VBP for_IN these_DT different_JJ questions_NNS ._SENT For_IN example_NN ,_, randomized_VBD allocation_NN of_IN participants_NNS to_TO an_DT intervention_NN and_CC control_NN group_NN is_VBZ held_VBN to_TO be_VB better_JJR than_IN non-random_NN allocation_NN for_IN controlling_VBG bias_NN in_IN intervention_NN studies_NNS ._SENT This_DT is_VBZ not_RB merely_RB a_DT matter_NN of_IN logic_NN ,_, common_JJ sense_NN or_CC faith_NN :_: non-random_NN allocation_NN usually_RB results_VBZ in_IN more_JJR optimistic_JJ differences_NNS between_IN intervention_NN and_CC control_NN groups_NNS than_IN does_VBZ random_JJ allocation_NN ._SENT Similarly_RB ,_, in_IN observational_JJ study_NN designs_NNS for_IN assessing_VBG the_DT accuracy_NN of_IN diagnostic_JJ tests_NNS ,_, independent_JJ interpretation_NN of_IN the_DT tests_NNS that_WDT are_VBP being_VBG compared_VBN is_VBZ known_VBN to_TO result_VB in_IN less_JJR optimistic_JJ reports_NNS of_IN test_NN performance_NN ._SENT Although_IN most_JJS guidelines_NNS for_IN critical_JJ appraisal_NN are_VBP not_RB comprehensive_JJ or_CC fully_RB rigorous_JJ ,_, they_PP provide_VBP an_DT effective_JJ filter_NN for_IN the_DT reliability_NN and_CC validity_NN of_IN health_NN care_NN research_NN that_WDT screens_VBZ out_RP about_RB 98_CD %_NN or_CC more_JJR of_IN the_DT medical_JJ research_NN literature_NN as_IN not_RB being_VBG ready_JJ for_IN clinical_JJ use_NN ._SENT Of_IN those_DT studies_NNS that_WDT make_VBP it_PP through_IN the_DT filter_NN ,_, systematic_JJ reviews_NNS provide_VBP the_DT firmest_JJS base_NN for_IN the_DT application_NN of_IN evidence_NN in_IN practice_NN ;_: the_DT past_JJ decade_NN has_VBZ seen_VBN the_DT Cochrane_NP Collaboration_NP forging_VBG a_DT world_NN wide_JJ effort_NN to_TO summarize_VB evidence_NN concerning_VBG the_DT effects_NNS of_IN health_NN care_NN interventions_NNS ._SENT Once_IN individual_JJ studies_NNS have_VBP been_VBN assembled_VBN and_CC graded_VBN for_IN quality_NN ,_, the_DT collected_VBN evidence_NN then_RB can_MD be_VB used_VBN to_TO make_VB recommendations_NNS for_IN practice_NN ,_, preferably_RB with_IN each_DT recommendation_NN being_VBG labeled_VBN according_VBG to_TO the_DT level_NN of_IN evidence_NN that_WDT supports_VBZ it_PP ._SENT Various_JJ systems_NNS for_IN indicating_VBG the_DT level_NN of_IN evidence_NN for_IN collected_VBN evidence_NN are_VBP available_JJ ,_, for_IN example_NN ,_, from_IN the_DT Centre_NP for_IN Evidence-Based_JJ Medicine_NN in_IN Oxford_NP and_CC in_IN EBM_NP books_NNS ._SENT Some_DT difficulties_NNS with_IN the_DT term_NN Evidence-Based_JJ Medicine_NN |_SYM Many_JJ objections_NNS to_TO EBM_NP are_VBP based_VBN on_IN the_DT notion_NN that_IN it_PP advocates_VBZ cook-book_NN medicine_NN ,_, that_WDT is_VBZ ,_, treating_VBG patients_NNS strictly_RB according_VBG to_TO a_DT formula_NN or_CC algorithm_NN derived_VBN from_IN a_DT research_NN study_NN ._SENT In_IN fact_NN ,_, this_DT was_VBD never_RB intended_VBN by_IN the_DT advocates_NNS of_IN EBM_NP ,_, but_CC it_PP was_VBD perhaps_RB not_RB initially_RB clearly_RB emphasized_VBD that_DT evidence_NN from_IN research_NN can_MD be_VB no_RB more_JJR than_IN one_CD component_NN of_IN any_DT clinical_JJ decision_NN ._SENT Other_JJ key_JJ components_NNS are_VBP the_DT circumstances_NNS of_IN the_DT patient_JJ (_( as_RB assessed_VBN through_IN the_DT expertise_NN of_IN the_DT clinician_NN )_) ,_, and_CC the_DT preferences_NNS of_IN the_DT patient_NN ._SENT Just_RB how_WRB research_NN evidence_NN ,_, clinical_JJ circumstances_NNS ,_, and_CC patients_NNS '_POS wishes_NNS are_VBP to_TO be_VB combined_VBN to_TO derive_VB an_DT optimal_JJ decision_NN has_VBZ not_RB been_VBN clearly_RB stated_VBN ,_, except_IN that_DT "_`` clinical_JJ judgment_NN and_CC expertise_NN "_'' are_VBP viewed_VBN as_RB essential_JJ to_TO success_NN ._SENT Figure_NP 1_CD |_SYM Basic_JJ elements_NNS of_IN clinical_JJ decision_NN making_VBG Basic_JJ elements_NNS of_IN clinical_JJ decision_NN making_VBG Even_RB more_RBR problematic_JJ ,_, the_DT term_NN evidence_NN is_VBZ commonly_RB used_VBN for_IN many_JJ types_NNS of_IN evidence_NN of_IN relevance_NN to_TO clinical_JJ practice_NN ,_, not_RB just_RB health_NN care_NN research_NN evidence_NN ._SENT For_IN example_NN ,_, clinicians_NNS collect_VBP evidence_NN of_IN patients_NNS '_POS circumstances_NNS and_CC wishes_NNS ._SENT Thus_RB ,_, it_PP is_VBZ hardly_RB surprising_JJ that_IN the_DT term_NN evidence-based_JJ medicine_NN is_VBZ confusing_VBG to_TO many_JJ ,_, who_WP do_VBP not_RB appreciate_VB that_IN its_PP$ evidence_NN is_VBZ narrowly_RB defined_VBN as_IN having_VBG to_TO do_VB with_IN systematic_JJ observations_NNS from_IN certain_JJ types_NNS of_IN research_NN ._SENT The_DT very_JJ name_NN has_VBZ been_VBN an_DT impediment_NN to_TO getting_VBG across_IN its_PP$ main_JJ objective_NN ,_, namely_RB ,_, that_DT health_NN care_NN research_NN is_VBZ nowadays_RB producing_VBG important_JJ results_NNS that_WDT ,_, if_IN applied_VBN ,_, can_MD benefit_VB patients_NNS more_JJR than_IN the_DT treatments_NNS that_IN clinicians_NNS are_VBP experienced_VBN in_IN recommending_VBG ._SENT Using_VBG the_DT technical_JJ definition_NN of_IN EBM_NP ,_, evidence_NN from_IN heath_NN care_NN research_NN is_VBZ a_DT modern_JJ ,_, never-before-available_JJ complement_NN to_TO traditional_JJ medicine_NN ._SENT Perhaps_RB a_DT better_JJR name_NN would_MD be_VB "_`` certain-types-of-high-quality-and-clinically-relevant-evidence-from-health-care-research-in-support-of-health-care-decision-making_JJ "_'' ..._: an_DT accurate_JJ but_CC mind-numbing_JJ descriptor_NN ._SENT Philosophical_JJ issues_NNS --_: from_IN a_DT lay_JJ perspective_NN |_SYM The_DT main_JJ original_JJ paper_NN on_IN EBM_NP proposed_VBD EBM_NP as_IN a_DT paradigm_NN shift_NN ,_, based_VBN on_IN Thomas_NP Kuhn_NP 's_POS definition_NN of_IN paradigms_NNS :_: ways_NNS of_IN looking_VBG at_IN the_DT world_NN that_WDT define_VBP both_CC the_DT problems_NNS that_WDT can_MD be_VB legitimately_RB addressed_VBN and_CC the_DT range_NN of_IN admissible_JJ evidence_NN that_WDT may_MD bear_VB on_IN their_PP$ solution_NN ._SENT Nevertheless_RB ,_, it_PP is_VBZ fair_JJ to_TO say_VB that_IN not_RB very_RB much_JJ attention_NN was_VBD paid_VBN by_IN the_DT originators_NNS of_IN EBM_NP to_TO the_DT philosophy_NN of_IN science_NN ._SENT It_PP is_VBZ also_RB easy_JJ to_TO agree_VB with_IN Alan_NP Chalmers_NP that_IN most_JJS scientists_NNS and_CC EBM_NN advocates_NNS are_VBP ignorant_JJ of_IN the_DT philosophy_NN of_IN science_NN and_CC give_VB little_RB or_CC no_RB thought_VBN to_TO constructing_VBG a_DT philosophical_JJ basis_NN for_IN their_PP$ activities_NNS ._SENT According_VBG to_TO Guba_NP and_CC Lincoln_NP ,_, in_IN the_DT basic_JJ science_NN that_WDT underpins_VBZ traditional_JJ medicine_NN ,_, the_DT workings_NNS of_IN the_DT human_JJ body_NN and_CC basic_JJ mechanisms_NNS of_IN disease_NN can_MD be_VB discovered_VBN by_IN observations_NNS of_IN an_DT individual_JJ human_NN or_CC organism_NN using_VBG instruments_NNS that_WDT are_VBP objective_JJ and_CC bias_NN free_JJ ._SENT These_DT mechanisms_NNS then_RB can_MD be_VB discerned_VBN by_IN inductive_JJ logic_NN and_CC known_VBN to_TO a_DT certainty_NN ._SENT By_IN contrast_NN ,_, applied_VBN research_NN deals_NNS with_IN more_JJR complex_JJ phenomena_NNS than_IN disease_NN mechanisms_NNS ;_: often_RB relies_VBZ on_IN experimentation_NN rather_RB than_IN (_( just_RB )_) observation_NN ;_: recognizes_VBZ that_IN observations_NNS of_IN complex_JJ phenomena_NNS can_MD be_VB biased_VBN and_CC takes_VBZ measures_NNS to_TO reduce_VB bias_NN ;_: has_VBZ groups_NNS of_IN patients_NNS as_IN the_DT basis_NN of_IN observation_NN ;_: uses_VBZ probabilities_NNS to_TO judge_VB truth_NN ,_, rather_RB than_IN expecting_VBG certainty_NN ;_: and_CC uses_VBZ deductive_JJ and_CC Bayesian_JJ logic_NN to_TO progress_VB ._SENT Certainly_RB ,_, there_EX are_VBP differences_NNS between_IN the_DT approaches_NNS of_IN basic_JJ and_CC applied_JJ research_NN ,_, but_CC are_VBP they_PP mutually_RB exclusive_JJ ,_, as_RB in_IN a_DT paradigm_NN shift_NN ,_, or_CC complementary_JJ ways_NNS of_IN knowing_VBG ,_, as_RB in_IN a_DT pluralistic_JJ version_NN of_IN epistemology_NN ?_SENT The_DT latter_JJ view_NN seems_VBZ to_TO be_VB more_RBR tenable_JJ ._SENT The_DT expectation_NN of_IN EBM_NP that_IN doctors_NNS should_MD keep_VB abreast_JJ of_IN evidence_NN from_IN (_( certain-types-of-health-care-_NN )_) research_NN raises_VBZ many_JJ issues_NNS ._SENT First_NP ,_, what_WP is_VBZ "_`` valid_JJ "_'' health_NN care_NN research_NN ?_SENT Second_RB ,_, what_WP are_VBP the_DT "_`` best_JJS "_'' findings_NNS from_IN this_DT research_NN ?_SENT Third_JJ ,_, when_WRB is_VBZ health_NN care_NN research_NN "_`` ready_JJ "_'' for_IN application_NN ?_SENT Fourth_JJ and_CC fifth_JJ ,_, to_TO whom_WP and_CC how_WRB does_VBZ one_PP apply_VB valid_JJ and_CC ready_JJ evidence_NN from_IN health_NN care_NN research_NN ?_SENT EBM_NP provides_VBZ a_DT set_NN of_IN increasingly_RB sophisticated_JJ tools_NNS for_IN addressing_VBG these_DT questions_NNS ,_, but_CC ,_, at_IN present_NN ,_, the_DT result_NN is_VBZ only_RB partly_RB as_RB good_JJ as_IN EBM_NP advocates_NNS hope_VBP it_PP will_MD become_VB ._SENT Meanwhile_RB there_EX is_VBZ much_JJ to_TO criticise_VB about_IN EBM_NP from_IN both_DT philosophical_JJ (_( AV_NP Kulkarni_NP ,_, personal_JJ communication_NN ,_, 2000_CD )_) and_CC practical_JJ perspectives_NNS ._SENT For_IN example_NN ,_, it_PP is_VBZ difficult_JJ to_TO be_VB smug_JJ about_IN the_DT superiority_NN of_IN the_DT research_NN methods_NNS advocated_VBN by_IN EBM_NP when_WRB the_DT results_NNS of_IN studies_NNS that_WDT are_VBP similar_JJ methodologically_RB not_RB infrequently_RB disagree_VB with_IN one_CD another_DT ._SENT Meanwhile_RB ,_, it_PP has_VBZ been_VBN shown_VBN that_IN the_DT findings_NNS of_IN observational_JJ studies_NNS agree_VBP more_RBR often_RB than_IN not_RB with_IN the_DT findings_NNS of_IN allegedly_RB more_JJR potent_JJ RCTs_NP ._SENT While_IN holes_NNS can_MD be_VB picked_VBN in_IN these_DT arguments_NNS against_IN the_DT ascendancy_NN of_IN RCTs_NP ,_, there_EX is_VBZ no_DT way_NN to_TO win_VB the_DT argument_NN without_IN a_DT universal_JJ standard_NN of_IN truth_NN ._SENT Furthermore_RB ,_, the_DT issue_NN of_IN when_WRB a_DT research_NN finding_NN is_VBZ ready_JJ for_IN clinical_JJ application_NN remains_VBZ mired_VBN in_IN the_DT lack_NN of_IN a_DT satisfactory_JJ resolution_NN of_IN how_WRB findings_NNS from_IN groups_NNS can_MD be_VB applied_VBN to_TO individuals_NNS ._SENT For_IN one_CD thing_NN ,_, our_PP$ understanding_NN of_IN how_WRB to_TO determine_VB what_WP patients_NNS want_VBP is_VBZ primitive_JJ ._SENT Also_RB problematic_JJ ,_, the_DT circumstances_NNS in_IN which_WDT patients_NNS are_VBP treated_VBN can_MD vary_VB widely_RB from_IN location_NN to_TO location_NN (_( including_VBG locations_NNS that_WDT are_VBP right_JJ across_IN the_DT street_NN from_IN one_CD another_DT )_) :_: the_DT resources_NNS ,_, expertise_NN and_CC patients_NNS are_VBP often_RB quite_RB different_JJ and_CC the_DT same_JJ research_NN evidence_NN cannot_MD be_VB applied_VBN in_IN the_DT same_JJ way_NN ,_, or_CC not_RB at_IN all_DT ._SENT Finally_RB ,_, we_PP do_VBP not_RB have_VB convincing_JJ studies_NNS showing_VBG that_DT patients_NNS whose_WP$ clinicians_NNS practise_VBP EBM_NN are_VBP better_JJR off_RP than_IN those_NNS whose_WP$ clinicians_NNS do_VBP not_RB practise_VB EBM_NP :_: no_DT one_CD has_VBZ done_VBN a_DT randomized_VBN controlled_JJ trial_NN of_IN EBM_NP with_IN patient_JJ outcomes_NNS as_IN the_DT measure_NN of_IN success_NN ._SENT Such_PDT a_DT trial_NN would_MD be_VB impossible_JJ to_TO do_VB as_IN the_DT control_NN group_NN could_MD not_RB be_VB effectively_RB isolated_VBN from_IN the_DT research_NN that_IN EBM_NP is_VBZ attempting_VBG to_TO transfer_VB ,_, and_CC it_PP would_MD be_VB regarded_VBN as_RB unethical_JJ to_TO attempt_VB to_TO do_VB so_RB ._SENT This_DT situation_NN is_VBZ unfortunate_JJ in_IN the_DT sense_NN that_IN ,_, even_RB if_IN it_PP is_VBZ accepted_VBN that_IN current_JJ research_NN is_VBZ generating_VBG valuable_JJ findings_NNS for_IN health_NN care_NN ,_, there_EX are_VBP many_JJ questions_NNS about_RB whether_IN the_DT EBM_NP movement_NN is_VBZ doing_VBG anything_NN useful_JJ to_TO accelerate_VB the_DT transfer_NN of_IN these_DT findings_NNS into_IN practice_NN ._SENT Nevertheless_RB ,_, we_PP do_VBP have_VB limited_JJ evidence_NN that_IN the_DT concepts_NNS of_IN EBM_NP are_VBP teachable_JJ ._SENT David_NP Hume_NP and_CC his_PP$ followers_NNS took_VBD pains_NNS to_TO point_VB out_RP the_DT differences_NNS between_IN is_VBZ and_CC ought_MD ._SENT The_DT is_VBZ of_IN EBM_NP is_VBZ that_DT science_NN is_VBZ producing_VBG new_JJ and_CC better_JJR ways_NNS of_IN predicting_VBG ,_, detecting_VBG and_CC treating_VBG disease_NN than_IN were_VBD imaginable_JJ at_IN the_DT middle_NN of_IN the_DT past_JJ century_NN ._SENT The_DT ought_MD of_IN the_DT EBM_NP movement_NN ,_, which_WDT annoys_VBZ many_JJ practitioners_NNS ,_, and_CC would_MD perturb_VB Hume_NP and_CC his_PP$ followers_NNS ,_, is_VBZ that_IN EBM_NP advocates_NNS believe_VBP that_IN clinicians_NNS ought_MD to_TO be_VB responsible_JJ for_IN keeping_VBG up_RP to_TO date_VB with_IN these_DT advances_NNS and_CC ought_MD to_TO be_VB prepared_VBN to_TO offer_VB them_PP to_TO patients_NNS ._SENT Thus_RB ,_, EBM_NP has_VBZ taken_VBN on_IN the_DT tones_NNS of_IN a_DT moral_JJ imperative_NN ._SENT But_CC it_PP is_VBZ premature_JJ to_TO get_VB very_RB preachy_JJ about_IN the_DT ought_MD of_IN EBM_NP ,_, not_RB that_IN this_DT has_VBZ stopped_VBN EBM_NP 's_POS more_JJR ardent_JJ advocates_NNS ._SENT Worse_RBR still_RB ,_, the_DT interventions_NNS that_IN advocates_NNS of_IN EBM_NP insist_VBP ought_MD to_TO be_VB provided_VBN in_IN all_DT appropriate_JJ individual_JJ circumstances_NNS would_MD undoubtedly_RB have_VB some_DT important_JJ adverse_JJ effects_NNS ._SENT For_IN one_CD ,_, full_JJ implementation_NN would_MD cost_VB much_RB more_JJR than_IN the_DT resources_NNS currently_RB available_JJ for_IN health_NN care_NN ,_, even_RB accounting_VBG for_IN some_DT cost_NN effective_JJ innovations_NNS and_CC deletion_NN of_IN existing_JJ but_CC ineffective_JJ practices_NNS ._SENT The_DT increased_VBN costs_NNS of_IN care_NN would_MD lead_VB to_TO unaddressed_JJ (_( let_VB alone_RB resolved_VBN )_) dilemmas_NNS in_IN distributive_JJ justice_NN ._SENT Second_RB ,_, interventions_NNS that_WDT save_VBP lives_NNS and_CC reduce_VB suffering_NN in_IN the_DT short_JJ term_NN may_MD end_VB up_RP prolonging_VBG life_NN beyond_IN the_DT point_NN of_IN senescence_NN and_CC misery_NN ._SENT EBM_NN advocates_NNS try_VBP to_TO ameliorate_VB the_DT latter_JJ problem_NN by_IN declaring_VBG that_IN patients_NNS '_POS values_NNS ought_MD to_TO be_VB incorporated_VBN into_IN clinical_JJ decisions_NNS ,_, but_CC without_IN assuring_VBG that_IN we_PP know_VBP how_WRB to_TO do_VB this_DT ._SENT Indeed_RB ,_, there_EX is_VBZ a_DT continuing_VBG tension_NN here_RB between_IN the_DT consequentialist_NN ,_, population-based_JJ origins_NNS of_IN epidemiology_NN (_( doing_VBG the_DT greatest_JJS good_JJ for_IN the_DT greatest_JJS number_NN )_) ,_, which_WDT generates_VBZ most_JJS of_IN the_DT best_JJS evidence_NN that_IN EBM_NP advocates_NNS hope_VBP to_TO convince_VB practitioners_NNS and_CC patients_NNS to_TO pay_VB attention_NN to_TO ,_, and_CC the_DT deontological_JJ or_CC individualistic_JJ approach_NN of_IN medicine_NN ,_, doing_VBG the_DT greatest_JJS good_JJ for_IN the_DT individual_JJ patient_NN ,_, which_WDT practitioners_NNS are_VBP sworn_VBN to_TO do_VB ._SENT Although_IN some_DT components_NNS of_IN EBM_NP have_VBP been_VBN derided_VBN as_IN representing_VBG ultrapragmatic_JJ utilitarianism_NN ,_, EBM_NP does_VBZ n't_RB offer_VB a_DT credible_JJ solution_NN to_TO this_DT tension_NN ,_, nor_CC even_RB take_VB a_DT clear_JJ stance_NN on_IN it_PP ,_, perhaps_RB reflecting_VBG the_DT dual_JJ origins_NNS of_IN many_JJ EBM_NP advocates_NNS :_: most_JJS of_IN the_DT leaders_NNS are_VBP trained_VBN in_IN both_DT epidemiology_NN and_CC a_DT clinical_JJ discipline_NN ,_, and_CC do_VBP both_DT research_NN and_CC clinical_JJ practice_NN ._SENT In_IN weighing_VBG the_DT philosophical_JJ issues_NNS raised_VBN by_IN EBM_NP ,_, many_JJ epistemological_JJ issues_NNS certainly_RB merit_VBP intense_JJ discussion_NN ._SENT However_RB ,_, it_PP is_VBZ the_DT ethical_JJ issues_NNS that_IN I_PP believe_VBP to_TO be_VB of_IN highest_JJS concern_NN ._SENT Will_MD the_DT proceeds_NNS of_IN the_DT new_JJ science_NN of_IN medicine_NN be_VB fairly_RB distributed_VBN in_IN society_NN ?_SENT Given_VBN the_DT already_RB stupendous_JJ and_CC wildly_RB escalating_VBG costs_NNS of_IN health_NN care_NN ,_, driven_VBN particularly_RB by_IN newer_JJR diagnostic_JJ and_CC therapeutic_JJ interventions_NNS ,_, how_WRB can_MD resources_NNS be_VB optimally_RB and_CC fairly_RB allocated_VBN within_IN the_DT health_NN care_NN sector_NN and_CC across_IN all_DT sectors_NNS of_IN public_JJ expenditure_NN ?_SENT Can_MD the_DT long-term_JJ consequences_NNS (_( for_IN example_NN ,_, unproductive_JJ and_CC miserable_JJ longevity_NN )_) of_IN the_DT short-term_JJ gains_NNS that_WDT are_VBP regularly_RB documented_VBN by_IN health_NN care_NN research_NN continue_VBP to_TO be_VB ignored_VBN ?_SENT How_WRB can_MD patient_NN 's_POS wishes_NNS be_VB informed_VBN ,_, determined_VBN and_CC taken_VBN into_IN account_NN in_IN health_NN care_NN decision_NN making_NN ?_SENT Should_MD some_DT of_IN the_DT funds_NNS for_IN health_NN research_NN be_VB diverted_VBN into_IN some_DT other_JJ sector_NN (_( continuing_VBG education_NN ?_SENT )_) so_RB that_IN the_DT health_NN care_NN system_NN can_MD catch_VB up_RP to_TO the_DT current_JJ state_NN of_IN knowledge_NN ?_SENT Is_VBZ EBM_NP a_DT waste_NN of_IN time_NN if_IN we_PP lack_VBP adequate_JJ understanding_NN of_IN practical_JJ methods_NNS of_IN changing_VBG practitioner_NN and_CC patient_NN actions_NNS ?_SENT One_PP hopes_VBZ that_IN the_DT attention_NN of_IN philosophers_NNS will_MD be_VB drawn_VBN to_TO these_DT questions_NNS ,_, as_RB well_RB as_IN to_TO the_DT continuing_VBG debate_NN about_RB whether_IN EBM_NP is_VBZ a_DT new_JJ paradigm_NN and_CC whether_IN applied_VBN health_NN care_NN research_NN findings_NNS are_VBP more_RBR valid_JJ for_IN reaching_VBG practical_JJ decisions_NNS about_IN health_NN care_NN than_IN basic_JJ pathophysiological_JJ mechanisms_NNS and_CC the_DT unsystematic_JJ observations_NNS of_IN practitioners_NNS ._SENT Evidence-Based_JJ Medicine_NN has_VBZ evolved_VBN substantially_RB from_IN its_PP$ origins_NNS a_DT decade_NN ago_RB ,_, becoming_VBG less_RBR pretentious_JJ and_CC more_RBR practical_JJ ._SENT Nonetheless_RB ,_, it_PP must_MD continue_VB to_TO evolve_VB and_CC address_VB several_JJ important_JJ issues_NNS that_WDT will_MD otherwise_RB limit_VB its_PP$ value_NN as_IN an_DT adjunct_NN to_TO health_NN care_NN decisions_NNS ._SENT Pressing_JJ matters_NNS include_VBP agreement_NN on_IN what_WP constitutes_VBZ "_`` best_JJS "_'' evidence_NN ;_: appropriate_JJ generalization_NN beyond_IN research_NN projects_NNS ;_: accurate_JJ and_CC efficient_JJ communication_NN with_IN practitioners_NNS ,_, patients_NNS and_CC policy_NN makers_NNS ;_: and_CC moral_JJ issues_NNS including_VBG distributive_JJ justice_NN and_CC individual_JJ autonomy_NN ._SENT Given_VBN the_DT substantial_JJ investment_NN of_IN society_NN and_CC commerce_NN in_IN fundamental_JJ and_CC applied_JJ health_NN research_NN ,_, and_CC the_DT high_JJ expectations_NNS of_IN society_NN for_IN reducing_VBG the_DT burden_NN of_IN illness_NN ,_, attention_NN to_TO these_DT matters_NNS should_MD have_VB high_JJ priority_NN ._SENT The_DT author_NN is_VBZ one_CD of_IN the_DT originators_NNS of_IN the_DT concepts_NNS of_IN Evidence-Based_JJ Medicine_NN ,_, and_CC is_VBZ the_DT developer_NN and_CC editor_NN of_IN a_DT number_NN of_IN evidence-based_JJ publications_NNS ,_, including_VBG ACP_NN Journal_NP Club_NP ,_, acpjc.org_NP and_CC Best_NP Evidence_NN ;_: co-editor_NN for_IN Evidence-Based_JJ Medicine_NN ;_: coordinating_VBG editor_NN for_IN Evidence-Based_JJ Mental_NP Health_NP ,_, Evidence-Based_NP Nursing_NP ;_: associate_NN editor_NN for_IN WebMD_NP 's_POS Scientific_NP American_NP Medicine_NP ;_: and_CC advisory_JJ board_NN member_NN for_IN Clinical_JJ Evidence_NN ._SENT 